Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

BAG5 inhibits parkin and enhances dopaminergic neuron degeneration.

Neuron | Dec 16, 2004

http://www.ncbi.nlm.nih.gov/pubmed/15603737

Loss-of-function mutations in the parkin gene, which encodes an E3 ubiquitin ligase, are the major cause of early-onset Parkinson's disease (PD). Decreases in parkin activity may also contribute to neurodegeneration in sporadic forms of PD. Here, we show that bcl-2-associated athanogene 5 (BAG5), a BAG family member, directly interacts with parkin and the chaperone Hsp70. Within this complex, BAG5 inhibits both parkin E3 ubiquitin ligase activity and Hsp70-mediated refolding of misfolded proteins. BAG5 enhances parkin sequestration within protein aggregates and mitigates parkin-dependent preservation of proteasome function. Finally, BAG5 enhances dopamine neuron death in an in vivo model of PD, whereas a mutant that inhibits BAG5 activity attenuates dopaminergic neurodegeneration. This contrasts with the antideath functions ascribed to BAG family members and suggests a potential role for BAG5 in promoting neurodegeneration in sporadic PD through its functional interactions with parkin and Hsp70.

Pubmed ID: 15603737 RIS Download

Mesh terms: Adaptor Proteins, Signal Transducing | Amino Acid Sequence | Animals | Carrier Proteins | Cell Line, Tumor | Dopamine | HSP70 Heat-Shock Proteins | Humans | Mice | Molecular Sequence Data | NIH 3T3 Cells | Nerve Degeneration | Parkinson Disease | Proto-Oncogene Proteins c-bcl-2 | Rats | Ubiquitin-Protein Ligases

Research resources used in this publication

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

None

GO (Data, Gene Annotation)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.